Clinical Research Directory
Browse clinical research sites, groups, and studies.
Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)
Sponsor: Massachusetts General Hospital
Summary
The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcranial direct current stimulation (tDCS), a noninvasive method that uses low intensity electric currents delivered to the brain through stimulation electrodes on the scalp.
Official title: Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Cognitive Post-acute Sequelae of COVID-19 (PASC)
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2022-06-07
Completion Date
2026-06-15
Last Updated
2025-11-10
Healthy Volunteers
No
Interventions
Active tDCS
2 mA of anodal stimulation will be applied to the left prefrontal cortex over the F3 electrode based on the International 10-10 EEG system.
Sham tDCS
Sham stimulation will be applied to the left prefrontal cortex over the F3 electrode.
Locations (1)
Massachusetts General Hospital
Charlestown, Massachusetts, United States